Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Cancer Researcher Wins Cytation™ 3 in BioTek's Contest!

Published: Saturday, April 12, 2014
Last Updated: Friday, April 11, 2014
Bookmark and Share
Dr. Jeff Peterson wins Cytation™ 3 cell imaging multi-mode reader in "Think Possible" Application Contest.

BioTek congratulates Dr. Jeff Peterson of the Fox Chase Cancer Center in Pennsylvania for winning a new Cytation™ 3 Cell Imaging Multi-Mode Reader in BioTek's "Think Possible" Application Contest.

Entrants were judged on a short essay that they submitted, detailing the application that they think is possible for their specific research using the Cytation 3. As an Associate Professor, Dr. Peterson studies chemical biology and kinase signaling in cancer.

"Multiplexing of disparate assays using multiple detection modalities is the future," Dr. Peterson wrote as part of his essay. "Cytation 3 is the first instrument that I am aware of that bridges the gap between imaging-based phenotypic screening and targeted assays using biochemical readouts. When both approaches are feasible simultaneously, the debate between phenotypic and targeted screening approaches dissolves to reveal a new world of possibilities."

As Dr. Peterson noted in his essay, patent pending Cytation 3 provides both quantitative and phenotypic cellular analyses by combining automated digital fluorescence microscopy and conventional microplate detection in a single platform.

Multi-channel widefield fluorescence and brightfield imaging are supported using high-intensity LED light sources and onboard filter cubes, and automated functions allow increased throughput compared to manual microscopy systems.

Hybrid Technology™ multi-mode detection combines high sensitivity filter-based detection and flexible monochromator-based detection for unmatched assay versatility now and in the future. This modular, parallel data acquisition platform allows scientists to collect more meaningful data, increase sample throughput, and reduce experimental time.

Cytation 3 is the recipient of three awards since its launch: the MipTec New Product Innovation Award, the SelectScience "Scientists' Choice Award for Best Drug Discovery Product" Award, and Thermo Fisher Scientific "Extraordinary New Product Line Award". It is also a finalist in the 2014 Edison Awards® competition.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

DLReady Certification Awarded for Synergy 2 and Synergy HT Multi-Detection Microplate Readers
Awarded by Promega Corporation, this certification validates an instrument to the highest performance levels and standards for the Dual-Luciferase® Reporter Assay System.
Monday, November 06, 2006
Scientific News
Monovar Drills Down Into Cancer Genome
Rice, MD Anderson develop program to ID mutations in single cancer cells.
Autism and Cancer Share a Remarkable Number of Risk Genes
Researchers with the UC Davis Comprehensive Cancer Center, MIND Institute identify more than 40 common genes.
Number Of Known Genetic Risk Factors For Endometrial Cancer Doubled
An international collaboration of researchers has identified five new gene regions that increase a woman’s risk of developing endometrial cancer, one of the most common cancers to affect women, taking the number of known gene regions associated with the disease to nine.
Genetic Variant May Help Explain Why Labradors Are Prone To Obesity
A genetic variation associated with obesity and appetite in Labrador retrievers – the UK and US’s favourite dog breed – has been identified by scientists at the University of Cambridge. The finding may explain why Labrador retrievers are more likely to become obese than dogs of other breeds.
How Scientists Use DNA to Track Disease Outbreaks
They’re the top questions on everyone’s mind when a new disease outbreak happens: where did the virus come from? When did this happen? How long has it been spreading in a particular country or group of people?
Genetic Risk Factors of Disparate Diseases Share Similar Biological Underpinnings
Penn Institute for Biomedical Informatics and colleagues identify "roadmap" of disease mechanisms to identify candidate drug targets.
Stem Cells Know How to Unwind
Research led by the Babraham Institute with collaborators in the UK, Canada and Japan has revealed a new understanding of how an open genome structure supports the long-term and unrestricted developmental potential in embryonic stem cells.
Childhood Asthma Research Receives $2M
Research into the impact of a child’s upbringing and social and physical environments on the development of asthma will receive $2 million to tackle the condition that affects as many as one in three Canadians.
Five New Breast Cancer Genes Found
Discovery of mutations paves the way for personalised treatment of breast cancer.
Cell Transplant Treats Parkinson’s in Mice
A University of Wisconsin—Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!